Indications and Purposes
| 1 Indications And Usage Cotellic ® Is Indicated For The Treatment Of Patients With Unresectable Or Metastatic Melanoma With A Braf V600e Or V600k Mutation, In Combination With Vemurafenib. Cotellic ® Is A Kinase Inhibitor Indicated For The Treatment Of Patients With Unresectable Or Metastatic Melanoma With A Braf V600e Or V600k Mutation, In Combination With Vemurafenib. ( 1 , 14 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Cobimetinib Fumarate |
|
ZINC60325170 |